The content provided on this website is for informational or educational purposes only and is not a substitute for medical advice or treatment for any medical conditions. Consult a physician regarding the applicability of any information and recommendations with respect to your health condition.

Reproduction or republication is strictly prohibited without prior written permission.

60 Resveratrol Health Benefits

Reported by Online Medical Researchers

Home

Resveratrol

Resveratrol and Lung Cancer

The red wine compound Resveratrol has, in many researches, exhibited unmistakable anti-carcinogenic properties that hinder the onset or growth of various human cancer cells like prostrate, stomach, thyroid, colon, skin and pancreatic cancers.

Resveratrol’s Anti-Carcinogenic Traits

One trait that stands out is its ability to induce apoptosis or death signals that cause tumor cells to self-destruct. Unlike healthy cells, tumor cells replicate rapidly and do not respond to cellular death signals. But Resveratrol at the right dose has been shown to induce cancer cell deaths.

Resveratrol is also known to inhibit tumor invasion and angiogenesis, cancer cells spread to normal cells by means of enzyme action of the matrix metalloproteinase. Resveratrol has shown it inhibits this activity in one type of cancer, not all. The metastasis of tumor cells to other organs is achieved over new blood vessels developed for the purposes called angiogenesis. Resveratrol inhibits this in vitro.

Resveratrol and Lung Cancer Treatment

In a number of independent researches, oral administration of Resveratrol in animal subjects inhibited esophageal, mammary (breast) and intestinal cancers induced by artificial carcinogens in vitro. But some results have been mixed.

Even in colon cancer treatment, oral administration on mice that are genetically predisposed to colon cancer was generally mixed as those injected with carcinogens responded better. Lung tumor cell treatment using Resveratrol proved to be less encouraging or promising. Oral intake was shown not effective in treating lung cancer induced by cigarette carcinogens.

On the other hand, topical application of Resveratrol in lab mice before and after UVB exposures shows that skin damage is reduced and the incidence of skin melanoma is decreased. Again, oral administration failed to treat mice inoculated with skin cancer cells.

Clinical tests are currently in the pipe to further confirm Resveratrol’s efficacy as an anticancer agent in as many forms of tumor growth as possible. These tests will attempt to determine the proper concentration of Resveratrol as well. Initial studies on human metabolism do not indicate that higher levels of dietary intake may result in the desired anti-carcinogenic effect of Resveratrol.

By Admin, Resveratrols.org

Comment/Publish Your Articles Here